|4May 31, 4:30 PM ET

Cyclacel Pharmaceuticals, Inc. 4

4 · Cyclacel Pharmaceuticals, Inc. · Filed May 31, 2016

Insider Transaction Report

Form 4
Period: 2016-05-26
Transactions
  • Award

    Option

    2016-05-26+15,00015,000 total
    Exercise: $0.43From: 2017-05-26Exp: 2026-05-26Common Stock (15,000 underlying)
Footnotes (1)
  • [F1]These options were granted to Dr. Bacopoulos for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc.

Documents

1 file
  • 4
    t1601438_x1-bacopoulos.xmlPrimary

    OWNERSHIP DOCUMENT